For example, RBM4 inhibits the apoptosis of breast cancer cells by upregulating the expression of IR‐B and MCL‐1S (Lin et al., 2014) and RBM33 participates in promoting proliferation in various cancers (Li et al., 2021). Here, RBM33 is linked to breast carcinoma.